That is necessary, due to the fact that the way a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be reliable. Simply put, we have to understand how these proteins fold if we want a drug to work. Historically, this has been an experimental process (jeff brown biotech stock). And now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much simpler to create drugs that do what they're created to do. This was an advancement nearly nobody noticed. But it's going to have extensive ramifications for treating illness. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be a lot of investment chances in this area, too. Shifting topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown biotech stock pick for 2020). That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it pulled back possibly considerably before going greater - jeff brown prediction for 2021. I have actually been covering bitcoin for a long time now. One of the very first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time. We were primarily educating readers. However that's not the huge concern any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So think of that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. diplomatic relations. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are so numerous great personal business on the verge of striking the general public markets And I have actually been working on a brand-new way for you to invest even prior to these companies go public.
This opportunity has been building over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the details. Go right here to reserve your area free of charge.
Emma Walsh here, handling editor of the Journal. Regular Journal readers know that tech isn't our normal beat (jeff brown investor prediction). And when it concerns tech investing, we leave it to the professionals. Thankfully, we have a number of such experts in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing specialists we know (artificial intelligence). In fact, he had a number of triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the huge picture and forecast what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and much more. These trends are experiencing rapid development and producing incredible chances for investors. I wish to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. tech predictions. But regardless of what numerous readers might think, this is a pattern that's simply starting. Although the COVID-19 pandemic interfered with supply chains last year, an excellent 250 million 5G-enabled gadgets were still offered.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (melania trump). Losing 2 months of manufacturing and sales really affects the number of 5G gadgets are sold in the calendar year. When you think about all of that, selling 250 million systems is remarkable. More significantly, the delays brought on by the pandemic produced a lots of pent-up demand. And that need is now going to be pressed into 2021. In truth, I predict that more than 500 million 5G gadgets will be delivered in 2021 - first lady. And that's not my only 5G forecast When I have actually spoken about 5G in the past, I have actually explained its three various stages.
In Phase 2, 5G gadgets go on sale. 5G phones and other products begin to reach consumers. And in Stage 3, 5G services start to be provided (jeff brown biotech stock pick for 2020). That's when we start to see applications working on 5G networks. Consider things like huge multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Stage Three by this summer. This begins something of a virtuous cycle: The majority of people don't actually appreciate the innovation. However they will care if there are exciting applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In fact, 5G is going to open up a suite of amazing applications: self-driving vehicles, the Web of Things, robotic surgical treatment, and more. All of these technologies need 5G. The investment opportunities going forward will be huge. Stepping away from 5G, the next important technology I anticipate in 2021 is CRISPR genetic editing. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. But it is among the most amazing advancements in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software application.
The program can crash or not operate correctly. CRISPR uses a comparable idea but with our genetic code. "Typos" in our genome can result in disease. CRISPR can remedy these "typos." For years, CRISPR was mostly a niche innovation that wasn't well comprehended. And during that time, there were really only 3 companies running in this space. However things are altering. CRISPR is no longer simply theoretical. We're seeing real results. We're treating diseases and seeing that this innovation simply works. And as a result, a "second crop" of early-stage CRISPR companies is going public and delivering incredible returns. This entire industry is successfully a greenfield opportunity.
There's space for lots of business to exist in this space. jeff brown biotech stocks. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or three more hereditary editing business will hold their IPOs. Sticking with biotechnology, we are seeing amazing things happening at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its most current Alpha, Fold software can accurately forecast the folding of a protein based exclusively on its amino acid sequence with 92. 4% accuracy. That's important because the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be effective.
Historically, this has been a trial-and-error procedure. However now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to develop drugs that do what they're created to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however numerous drug therapies produced utilizing this technology. This was among those breakthroughs that nearly nobody noticed. But it's going to have extensive ramifications for treating disease. And, naturally, there will be a lot of investment chances in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it pulled back possibly considerably prior to going higher. I have actually been covering bitcoin for a long period of time now. Among the first research study reports I ever released was on bitcoin - last week. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anybody who followed my recommendation. But at the time of that preliminary recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
But no one is asking that question any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. exponential tech investor. Mass, Mutual is a 150-year-old organization. So believe about that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more reward forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and declares the details is up to date as of February 2021, but we could not separately confirm this claim. Offered Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down a precise figure at this minute. Brown is best understood for his sage-like ability to choose winning technology stocks. He spent more than 25 years researching technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an excellent point of view on the marketplace. He's always on the hunt for brand-new opportunities, and he shares a lot of his best picks in the Near Future Report.
That's high appreciation, however it's not absurdly reasoned. Brown has an exceptional credibility as a stock-picker, and he effectively predicted a few of the biggest economic occasions of the previous 20 years. Although he doesn't appear to release his choices to the general public, the service's success is a direct sign of Brown's stock-picking prowess. No one on Wall Street gets it ideal every time, however Jeff Brown's precise forecasts have actually earned him legions of devoted followers. That states a lot about his capability. The Near Future Report is released by Brownstone Research, a popular financial research publisher. Brownstone Research study provides several research services with a broad range of expertises - diplomatic relations.
The business is likewise connected with Bonner & Partners, another well-respected research study publisher - tech predictions. On its site, Brownstone states its objective is to supply retail financiers with professional-grade research study: "For too long, the very best financial investment research has actually not been available to specific financiers. It has actually been typically scheduled for investment banks, hedge funds, private equity, and high-net-worth clients. biotech stock. The mission of Brownstone Research study is to make that type of exclusive research study readily available to any investors looking to gain an edge in the markets. The objective is easy to deliver unique and lucrative financial investment research study discovered nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research, and he also works as the company's Chief Investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to offer its clients. After years of constant success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout the majority of America. If you understand even a bit about the market, you understand that he has a credibility as a King Midas of sorts. jeff brown latest prediction. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big project.
In reality, Brown thinks S.A.V. jeff brown 2021 predictions. might be "the biggest trend of the 2020s, and he's not alone. Examine out these quotes from other well-known S.A.V. bulls: Elon's next big act will be weding 2 cutting-edge technologies: synthetic intelligence and electrical cars. Musk hopes the mix will assist him establish the very first fully-autonomous, self-driving cars ever. It's nothing short of the automotive market's Holy Grail. As you understand, electric vehicles and self-driving cars and truck stocks have actually been substantial this year, but the Wall Street device has actually been huge on buzz without much tangible outcome. In spite of an extreme boost in competition over the previous couple of years, Brown still thinks Musk has the very best possibility of putting all of it together.
tech could be the magic string that ties everything together. S.A.V. represents Shared Autonomous Automobile, and it could be the future of transport. Basically, this technology would allow you to lease your cars and truck as an autonomous, self-driving taxi when you're not utilizing it. You just get out of the vehicle and press a button on an app that informs the automobile to "join the fleet." Next thing you understand, you're unwinding on your couch while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a significant chunk of the earnings. It sounds ridiculous, but it could be closed than you think.